Evidence map›Paper›PMID 41591840›Full record

ArticleNucleic acids research2026

NUP98 regulates orthoflavivirus replication through interaction with vRNA and can be targeted for antiviral purposes.

Marie B A Peters, Richard Lindqvist, Priyanka Madhu, Richard Lundmark, Ylva Ivarsson, Anna K Överby

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marie B A PetersDepartment of Clinical Microbiology, Umeå University, 90185 Umeå, Sweden.ORCID 0000-0001-8994-0864
Richard LindqvistDepartment of Clinical Microbiology, Umeå University, 90185 Umeå, Sweden.
Priyanka MadhuDepartment of Chemistry for Life Sciences, Uppsala University, 751 23 Uppsala, Sweden.
Richard LundmarkLaboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, 90187 Umeå, Sweden.
Ylva IvarssonDepartment of Chemistry for Life Sciences, Uppsala University, 751 23 Uppsala, Sweden.
Anna K ÖverbyDepartment of Clinical Microbiology, Umeå University, 90185 Umeå, Sweden.ORCID 0000-0001-6553-0940

Funding

Knut and Alice Wallenberg foundation 2024-0039Swedish research councilVR 2018-05851VR 2020-06224VR 2023-02810VR 2024-00390
6 · The paper itself

Abstract

The nuclear pore complex (NPC) is composed of multiple nucleoporins (NUPs) and enables the exchange of RNA and proteins between the nucleus and cytoplasm. NUP98 is one of the major components of the NPC, being involved in the RNA export pathway by interacting with several transport factors. Previous studies have suggested both proviral and antiviral functions of NUP98 in viral infection, yet little is known about its function in orthoflavivirus infection. In this study we show that NUP98 is a proviral cellular protein that is recruited to the cytoplasm during orthoflavivirus infection. We observe that NUP98 is found specifically in the vicinity of the replication vesicles during infections with tick-borne encephalitis virus, Japanese encephalitis virus, and yellow fever virus. Furthermore, using surface plasmon resonance, cross-link immunoprecipitation, and cross-link immunoprecipitation-sequencing we observe that the C-terminal domain of NUP98 directly interacts with a conserved site of the viral RNA (vRNA) in the E coding region promoting viral replication. We identified a peptide that binds to NUP98 that is antivirally active against several orthoflaviviruses by outcompeting the binding between NUP98 and vRNA, making NUP98 an attractive target for antiviral development.

Indexed as

Nuclear Pore Complex ProteinsRNA, ViralVirus ReplicationAnimalsAntiviral AgentsCytoplasmHumansProtein BindingAntiviral Agentsnuclear pore complex protein 98Nuclear Pore Complex ProteinsNup98 protein, humanRNA, Viral

Identifiers

PMID41591840
PMCPMC12839527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.